This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
HCA Healthcare (HCA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
HCA Healthcare (HCA) closed at $296.56 in the latest trading session, marking a +0.2% move from the prior day.
Select Medical (SEM) Up 21% Year to Date: More Room to Run?
by Zacks Equity Research
Select Medical (SEM) is well-poised for growth on the back of improved patient volumes, an expanding healthcare portfolio and solid cash-generating abilities.
Are Medical Stocks Lagging Aquestive Therapeutics (AQST) This Year?
by Zacks Equity Research
Here is how Aquestive Therapeutics (AQST) and HCA Healthcare (HCA) have performed compared to their sector so far this year.
Brokers Suggest Investing in HCA (HCA): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), HCA (HCA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)?
by Zacks Equity Research
Sector ETF report for FXH
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
HCA Healthcare (HCA) Recently Broke Out Above the 20-Day Moving Average
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?
5 Dividend Stocks With Strong Growth Prospects
by Sweta Killa
Dividend stocks like Toll Brothers (TOL), Darden Restaurants (DRI), Caterpillar (CAT), Microchip (MCHP) and HCA Healthcare (HCA) pose strong growth prospects.
4 Sector ETFs & Stocks to Bet on June Jobs Data
by Sanghamitra Saha
The U.S. economy added 209,000 jobs in June 2023, following a downwardly revised 306,000 in May, and below market forecasts of 225,000.
2 Soaring Stocks to Buy Now for Growth and Value
by Benjamin Rains
Let's dive into two stocks that have soared in 2023 and over the last decade that investors might want to buy for both near-term and long-term upside since they offer a wonderful combination of growth and value.
If You Invested $1000 in HCA Healthcare a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
UnitedHealth's (UNH) Suffering Continues: Should You Hold Tight?
by Zacks Equity Research
Each sub-segment of Optum, UnitedHealth's (UNH) health service business, is expected to continue delivering a solid performance, driving the overall segment's growth.
Molina (MOH) to Buy Bright Health's California Medicare Business
by Zacks Equity Research
Molina's (MOH) Brand New Day and Central Health Plan of California buyout complements Molina's Medicaid footprint and aligns with its 2024 Medi-Cal plan.
The Zacks Analyst Blog Highlights Microsoft, Anheuser-Busch InBev, HCA Healthcare, Delta Air Lines and TELUS
by Zacks Equity Research
Microsoft, Anheuser-Busch InBev, HCA Healthcare, Delta Air Lines and TELUS are included in this Analyst Blog.
Top Research Reports for Microsoft, Anheuser-Busch InBev & HCA Healthcare
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Anheuser-Busch InBev SA/NV (BUD) and HCA Healthcare (HCA).
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
HCA Healthcare (HCA) Boasts Earnings & Price Momentum: Should You Buy?
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
Zacks Industry Outlook Highlights HCA Healthcare, Universal Health, Tenet Healthcare and Community Health Systems
by Zacks Equity Research
HCA Healthcare, Universal Health, Tenet Healthcare and Community Health Systems have been highlighted in this Industry Outlook article.
4 Hospital Stocks in Focus Amid Improving Industry Trends
by Kaibalya Pravo Dey
Delayed elective procedures are boosting patient volumes for the Zacks Medical-Hospital industry players. HCA Healthcare (HCA), Universal Health (UHS), Tenet Healthcare (THC) and Community Health (CYH) are poised to gain from improving occupancy rates.
Factors That Make HCA Healthcare (HCA) a Lucrative Bet Now
by Zacks Equity Research
HCA Healthcare (HCA) remains well-poised for growth on the resumption of elective surgeries, acquisitions and strong cash-generation abilities.
3 Attractive Large-Caps For a Steady Approach
by Derek Lewis
Large-caps are typically less volatile, making them great considerations for those seeking a steady approach without spooky price swings.
UnitedHealth's (UNH) Program to Aid Georgia's Diabetic Patients
by Zacks Equity Research
UnitedHealth's (UNH) unit, UnitedHealthcare, extends its community-based program to improve the health conditions of Southwest Georgia's diabetic patients.
Are You Looking for a Top Momentum Pick? Why HCA Healthcare (HCA) is a Great Choice
by Zacks Equity Research
Does HCA Healthcare (HCA) have what it takes to be a top stock pick for momentum investors? Let's find out.
Here's How Much a $1000 Investment in HCA Healthcare Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Universal Health (UHS) Gains 3.7% as Pent-Up Surgeries Rise
by Zacks Equity Research
The pent-up demand for elective surgeries is expected to improve Universal Health's (UHS) patient admissions and patient days.